SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…
Matched conditions: SAFETY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 02:57 UTC
-
Mpox vaccine trial for babies launches in congo: could half a dose be enough?
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo. Half the children receive the standard vaccine dose, and the other half receive a half dose. The goal is to find the…
Matched conditions: SAFETY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 08, 2026 13:17 UTC
-
Lupus patients may benefit from engineered immune cells in early trial
Disease control TerminatedThis early-stage study tests a new treatment called RD06-04, which uses a patient's own immune cells modified to target and attack lupus-causing cells. The study involves 12 adults with moderate to severe lupus who have not responded well to standard treatments. The main goal is …
Matched conditions: SAFETY
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Researchers track safety of wrist artery access in 3,600 heart patients
Knowledge-focused OngoingThis study tracks how well and how safely doctors can reach the heart through a small artery in the wrist (distal radial artery) for procedures like angiograms. About 3,600 adults who need these heart procedures will be observed. The goal is to measure success rates and any compl…
Matched conditions: SAFETY
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
12,000 koreans monitored for vaccine side effects over 6 years
Knowledge-focused OngoingThis study tracks the safety of the Pfizer COVID-19 vaccine (BNT162b2) in 12,000 Korean adults who received it as part of routine care. Researchers will record any side effects, including serious ones, for up to 28 days after each dose. The goal is to gather real-world safety dat…
Matched conditions: SAFETY
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC